You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
啟迪藥業(000590.SZ):“年產4億支古漢養生精口服液技改配套工程項目”結項
格隆匯 07-07 20:38

格隆匯7月7日丨啟迪藥業(000590.SZ)公佈,公司於2023年7月6日召開的第十屆董事會臨時會議、第十屆監事會臨時會議審議通過了《關於募投項目結項並將節餘募集資金永久補充流動資金的議案》。同意公司將非公開發行股票募集資金投資項目中的“年產4億支古漢養生精口服液技改配套工程項目”進行結項。

截至公吿披露日,公司非公開發行股票募集資金投資項目已全部達到預定可使用狀態並已全部結項,同時為提高節餘募集資金使用效率,同意將募集資金投資項目結項後的節餘募集資金共計5594萬元(包含待使用募集資金支付的合同尾款、質保金和扣除手續費的現金管理取得的理財收益及活期利息收入,實際用於永久補充流動資金金額以轉出當日專户餘額為準)用於永久補充流動資金,並適時註銷相關募集資金專户。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account